One of the latest trends in the cosmetic industry is cosmetics with probiotics. These are cosmetic products that contain living non-pathogenic organisms which, when administered in adequate amounts, confer a health benefit. Their purpose in cosmetic products is to improve the barrier function of the skin, to inhibit the growth of the pathogen, to stimulate the wound healing process and action of immune cells. One of these products is also the Ao+MistTM, which we tested. During regular application, the skin should be smoother, and conditions of greasy, dry and sensitive skin are supposed to be improved.It contains nitrosifying bacteria Nitrosomonas eutropha D23 (N. eutropha D23) that converts ammonia in sweat to nitrite and nitric oxide. In an era of the increasing bacterial resistance to available antibiotics, nitric oxide appears as a promising topical broad-spectrum antimicrobial agent with a small likelihood of resistance development because of various mechanisms of action on pathogens. The main purpose of this work was to test the antimicrobial activity of nitrosifying bacteria N. eutropha D23 on Candida albicans, Pseudomonas aeruginosa, Staphylococcus aureus, and Aspergillus brasiliensis by the discs diffusion test method. First, we tested if the product contains bacteria N. eutropha D23, determined the optimal growth medium and grown them to a suitable concentration for further use. We also observed how different factors affect the growth and activity of these bacteria. The concentration of bacteria was determined by measuring the optical density at 600 nm. Their activity was determined by measuring the concentration of nitrite spectrophotometrically at 352 nm and 400 nm. Results showed that the cosmetic product Ao+MistTM, contains bacteria N. eutropha D23 with concentration 109 CFU/mL. The most optimal cultivation conditions were in liquid medium B at 30 °C in darkness and with constant mixing. Bacteria N. eutropha D23 showed no antimicrobial activity on any of the tested microorganisms. From our in vitro results we concluded that N. eutropha D23 does not prevent the growth of tested microorganisms, which is contrary to the published claims. To confirm this antimicrobial activity should be additionally tested with dilution test as well as in vivo, where synergistic action with the cells of the immune system could occur. Bacteria N. eutropha is just one of the nitric oxide delivery systems. Many new ones are also being developed to provide controlled nitric oxide release and safety to host cells.
|